Systemic inflammatory response predicts survival following curative resection of colorectal cancer

British Journal of Surgery

Volumn 90, Issue 2, 2003, Pages 215-219

  McMillan, D C ^a   Canna, K ^a   McArdle, C S ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN;

AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADOLESCENT; ADULT; AGED; C-REACTIVE PROTEIN; COLORECTAL NEOPLASMS; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0037329813     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4038     Document Type: Article

References (13)

1. McArdle CS, Hole DJ. Outcome following surgery for colorectal cancer: analysis by hospital after adjustment for case-mix and deprivation. Br J Cancer 2002; 86: 331-335.
2. Dorudi S, Kinrade E, Marshall NC, Feakins R, Williams NS, Bustin SA. Genetic detection of lymph node micrometastases in patients with colorectal cancer. Br J Surg 1998; 85: 98-100.
3. Vermeulen PB, Van den Eynden GG, Huget P, Goovaerts G, Weyler J, Lardon F et al. Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer. Br J Cancer 1999; 79: 316-322.
4. Frost P, Levin B. Clinical implications of metastatic process. Lancet 1992; 339: 1458-1461.
5. Schipper H, Turley EA, Baum M. A new biological framework for cancer research. Lancet 1996; 348: 1149-1151.
6. McMillan DC, Wotherspoon HA, Fearon KC, Sturgeon C, Cooke TG, McArdle CS. A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg 1995; 170: 319-322.
7. Nozoe T, Matsumata T, Kitamura M, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in colorectal cancer. Am J Surg 1998; 176: 335-338.
8. Nielsen HJ, Christensen IJ, Sorensen S, Moesgaard F, Brunner N. Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group. Ann Surg Oncol 2000; 7: 617-623.
9. Wigmore SJ, McMahon AJ, Sturgeon CM, Fearon KCH. Acute-phase protein response, survival and tumour recurrence in patients with colorectal cancer. Br J Surg 2001; 88: 255-260.
10. McMillan DC, Elahi MM, Sattar N, Angerson WJ, Johnstone J, McArdle CS. Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutr Cancer 2001; 41: 64-69.
11. Hart IR, Saini A. Biology of tumour metastasis. Lancet 1992; 339: 1453-1457.
12. Abramovitch R, Marikovsky M, Meir G, Neeman M. Stimulation of tumour growth by wound-derived growth factors. Br J Cancer 1999; 79: 1392-1398.
13. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539-545.